 Sample SizePatient Population: Sixty subjects will be enrolled in the study. To be able to assess the molecular alterations after ODM-201, exposure in different BC subtypes, subjects being either triple-negative, or ERHER2 negative, or HER2 positive, will be enrolled in the study. Twenty subjects with each of these subtypes will be included. 